Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1242556

"Rituximab: A Safe Treatment in a Patient With Refractory Felty Syndrome and Recurrent Infections"


Pukšić, Silva; Mitrović, Joško; Morović-Vergles, Jadranka
"Rituximab: A Safe Treatment in a Patient With Refractory Felty Syndrome and Recurrent Infections" // JCR: Journal of Clinical Rheumatology, 23 (2017), 1; 70-71 doi:10.1097/rhu.0000000000000440 (međunarodna recenzija, kratko priopcenje, znanstveni)


CROSBI ID: 1242556 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
"Rituximab: A Safe Treatment in a Patient With Refractory Felty Syndrome and Recurrent Infections"

Autori
Pukšić, Silva ; Mitrović, Joško ; Morović-Vergles, Jadranka

Izvornik
JCR: Journal of Clinical Rheumatology (1076-1608) 23 (2017), 1; 70-71

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kratko priopcenje, znanstveni

Ključne riječi
Rituximab, Felty Syndrome, Infections

Sažetak
Rituximab: A Safe Treatment in a Patient With Refractory Felty Syndrome and Recurrent Infections

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Pukšić, Silva; Mitrović, Joško; Morović-Vergles, Jadranka
"Rituximab: A Safe Treatment in a Patient With Refractory Felty Syndrome and Recurrent Infections" // JCR: Journal of Clinical Rheumatology, 23 (2017), 1; 70-71 doi:10.1097/rhu.0000000000000440 (međunarodna recenzija, kratko priopcenje, znanstveni)
Pukšić, S., Mitrović, J. & Morović-Vergles, J. (2017) "Rituximab: A Safe Treatment in a Patient With Refractory Felty Syndrome and Recurrent Infections". JCR: Journal of Clinical Rheumatology, 23 (1), 70-71 doi:10.1097/rhu.0000000000000440.
@article{article, author = {Puk\v{s}i\'{c}, Silva and Mitrovi\'{c}, Jo\v{s}ko and Morovi\'{c}-Vergles, Jadranka}, year = {2017}, pages = {70-71}, DOI = {10.1097/rhu.0000000000000440}, keywords = {Rituximab, Felty Syndrome, Infections}, journal = {JCR: Journal of Clinical Rheumatology}, doi = {10.1097/rhu.0000000000000440}, volume = {23}, number = {1}, issn = {1076-1608}, title = {"Rituximab: A Safe Treatment in a Patient With Refractory Felty Syndrome and Recurrent Infections"}, keyword = {Rituximab, Felty Syndrome, Infections} }
@article{article, author = {Puk\v{s}i\'{c}, Silva and Mitrovi\'{c}, Jo\v{s}ko and Morovi\'{c}-Vergles, Jadranka}, year = {2017}, pages = {70-71}, DOI = {10.1097/rhu.0000000000000440}, keywords = {Rituximab, Felty Syndrome, Infections}, journal = {JCR: Journal of Clinical Rheumatology}, doi = {10.1097/rhu.0000000000000440}, volume = {23}, number = {1}, issn = {1076-1608}, title = {"Rituximab: A Safe Treatment in a Patient With Refractory Felty Syndrome and Recurrent Infections"}, keyword = {Rituximab, Felty Syndrome, Infections} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font